Skip to main content
Call
RCMaka Home Health Risk Assessment, IHA, Home Risk Assessment

What is In-Home Assessment (Risk Adjustment)? Definition, Formula, and Benchmark

Reviewed by QuickIntell RCM Editorial Team · Last reviewed

Updated

Definition

An in-home assessment is a face-to-face encounter conducted in the patient's home, typically by a contracted nurse practitioner or physician, to identify and document chronic conditions for Medicare Advantage risk adjustment. IHAs improve HCC capture for members with limited primary care engagement but have faced OIG scrutiny for program integrity concerns.

Overview

An in-home assessment (IHA) is a face-to-face clinical encounter conducted in the patient's home — typically by a contracted nurse practitioner, physician assistant, or physician — to identify and document chronic conditions for Medicare Advantage (MA) risk adjustment. IHAs became prevalent in the 2010s as MA plans sought to improve HCC capture for members with limited engagement with primary care providers. The visits are typically coordinated by specialized IHA vendors (Matrix Medical Network, Signify Health acquired by CVS, ConcertCare) who schedule, conduct, and document the assessments.

Clinical content of IHAs includes: comprehensive health history review, medication reconciliation, physical examination, review of chronic conditions and functional status, preventive care screening, and identification of care coordination needs. Clinicians document findings in structured assessments that support subsequent ICD-10 claim coding for identified conditions.

The risk adjustment value proposition: MA members with limited primary care engagement often have under-documented chronic conditions, reducing their risk scores below their clinical reality. IHAs close this gap by bringing a face-to-face encounter to the patient's home, documenting conditions that would otherwise go unbilled. For plans, IHAs increase risk-adjusted revenue; for members, the assessments may identify care coordination needs and trigger referrals.

Regulatory scrutiny has been substantial. The Office of Inspector General has issued multiple reports questioning IHA program integrity, citing concerns that IHAs identify conditions without providing treatment, that documentation practices do not consistently reflect MEAT criteria, and that risk adjustment revenue generated from IHAs may exceed the clinical value provided. CMS has periodically considered policy changes affecting IHA-sourced diagnoses; some proposals have excluded IHA-only diagnoses (those not also documented by the member's primary care provider) from risk adjustment calculations.

Documentation requirements under CMS risk adjustment rules apply equally to IHA visits as to other face-to-face encounters: the visit must satisfy medical necessity criteria, documentation must support the diagnoses coded, and MEAT criteria should be demonstrable. Plans increasingly integrate IHA findings with primary care records and require follow-up visits to confirm IHA-identified conditions, strengthening program integrity.

For RCM operations, IHAs are typically managed by health plan risk-adjustment teams rather than individual provider practices. Practices may participate by: accepting IHA vendor scheduling with their patients, integrating IHA documentation into their EHR records, conducting follow-up visits triggered by IHA findings, and validating IHA-identified conditions through their own clinical encounters.

Strategic and compliance considerations include: IHA contract structures (fee per completed assessment vs. PMPM), vendor performance monitoring (assessment quality, documentation completeness, member satisfaction), compliance framework alignment (MEAT criteria, non-duplicative coding, follow-up coordination), and evolving CMS policy response (monitoring for rule changes affecting IHA-sourced diagnoses).

The CMS-HCC V28 transition and ongoing OIG focus have pushed MA plans toward more integrated risk adjustment approaches combining IHAs with primary care engagement, chart review, and condition-specific outreach. Pure IHA-only programs have faced increased scrutiny; programs combining IHA findings with primary care follow-up and treatment documentation are favored from a program-integrity perspective.

Industry benchmark

IHA completion rates: 50–80% of scheduled depending on outreach intensity. Per-assessment HCC capture: 2–5 new HCCs typical. OIG scrutiny: ongoing.

Worked example

A Medicare Advantage plan contracts with an IHA vendor to conduct assessments on 15,000 members with limited primary care engagement. 9,000 assessments are completed (60%). Average of 3.2 new HCCs identified per completed assessment, yielding 28,800 HCC captures. Documentation review validates 89% of captures; the remainder are excluded for documentation gaps. Risk score improvement contributes approximately $18M in additional CMS capitation. Program compliance includes primary care follow-up coordination and annual vendor documentation audits.

Frequently asked questions — In-Home Assessment (Risk Adjustment)

Do IHAs count as face-to-face encounters for risk adjustment?

Yes, when conducted by qualifying clinicians and documented appropriately. CMS has periodically considered policy changes limiting IHA-sourced diagnoses; current rules count IHA findings when documentation supports them.

What's the OIG concern with IHAs?

Program integrity — conditions identified without subsequent treatment, documentation not consistently reflecting MEAT, and risk adjustment revenue generated without commensurate clinical value. OIG has issued multiple reports; CMS policy response has been ongoing.

Should practices participate in IHA programs?

Participation considerations include patient care coordination, documentation integration with primary care, follow-up workflow for identified conditions, and compliance alignment with plan expectations. Clear contract terms and documentation standards support program integrity.

Disclaimer

This glossary entry is operational reference for revenue-cycle and medical-billing professionals. It is not legal, clinical, or contractual advice. Industry benchmarks cite named public sources where available; always verify against the current guidance from the authority body before relying on a number in a contract, policy, or compliance filing.